Case Report: Convalescent Plasma, a Targeted Therapy for Patients with CVID and Severe COVID-19

KFA van Damme; S Tavernier; N van Roy; E de Leeuw; J Declercq; C Bosteels; B Maes; M de Bruyne; D Bogaert; V Bosteels; L Hoste; L Naesens; P Maes; A Grifoni; D Weiskopf; A Sette; P Depuydt; E Van Braeckel; F Haerynck; Bart Lambrecht

doi:10.3389/fimmu.2020.596761

Case Report: Convalescent Plasma, a Targeted Therapy for Patients with CVID and Severe COVID-19

KFA van Damme, S Tavernier, N van Roy, E de Leeuw, J Declercq, C Bosteels, B Maes, M de Bruyne, D Bogaert, V Bosteels, L Hoste, L Naesens, P Maes, A Grifoni, D Weiskopf, A Sette, P Depuydt, E Van Braeckel, F Haerynck, Bart Lambrecht

Pulmonary Medicine

Research output: Contribution to journal › Article › Academic

46 Citations (Scopus)

24 Downloads (Pure)

Original language	English
Article number	596761
Journal	Frontiers in Immunology
Volume	11
DOIs	https://doi.org/10.3389/fimmu.2020.596761
Publication status	Published - 2020

Research programs

EMC MM-04-42-02

Access to Document

10.3389/fimmu.2020.596761

RePub-132417-OA.pdfFinal published version, 1.68 MB

http://hdl.handle.net/1765/132417

Cite this

van Damme, KFA., Tavernier, S., van Roy, N., de Leeuw, E., Declercq, J., Bosteels, C., Maes, B., de Bruyne, M., Bogaert, D., Bosteels, V., Hoste, L., Naesens, L., Maes, P., Grifoni, A., Weiskopf, D., Sette, A., Depuydt, P., Van Braeckel, E., Haerynck, F., & Lambrecht, B. (2020). Case Report: Convalescent Plasma, a Targeted Therapy for Patients with CVID and Severe COVID-19. Frontiers in Immunology, 11, Article 596761. https://doi.org/10.3389/fimmu.2020.596761

@article{590f29e7c6ba4ac5a18c2cba823f3ec2,

title = "Case Report: Convalescent Plasma, a Targeted Therapy for Patients with CVID and Severe COVID-19",

author = "{van Damme}, KFA and S Tavernier and {van Roy}, N and {de Leeuw}, E and J Declercq and C Bosteels and B Maes and {de Bruyne}, M and D Bogaert and V Bosteels and L Hoste and L Naesens and P Maes and A Grifoni and D Weiskopf and A Sette and P Depuydt and {Van Braeckel}, E and F Haerynck and Bart Lambrecht",

year = "2020",

doi = "10.3389/fimmu.2020.596761",

language = "English",

volume = "11",

journal = "Frontiers in Immunology",

issn = "1664-3224",

publisher = "Frontiers Media SA",

}

van Damme, KFA, Tavernier, S, van Roy, N, de Leeuw, E, Declercq, J, Bosteels, C, Maes, B, de Bruyne, M, Bogaert, D, Bosteels, V, Hoste, L, Naesens, L, Maes, P, Grifoni, A, Weiskopf, D, Sette, A, Depuydt, P, Van Braeckel, E, Haerynck, F & Lambrecht, B 2020, 'Case Report: Convalescent Plasma, a Targeted Therapy for Patients with CVID and Severe COVID-19', Frontiers in Immunology, vol. 11, 596761. https://doi.org/10.3389/fimmu.2020.596761

TY - JOUR

T1 - Case Report: Convalescent Plasma, a Targeted Therapy for Patients with CVID and Severe COVID-19

AU - van Damme, KFA

AU - Tavernier, S

AU - van Roy, N

AU - de Leeuw, E

AU - Declercq, J

AU - Bosteels, C

AU - Maes, B

AU - de Bruyne, M

AU - Bogaert, D

AU - Bosteels, V

AU - Hoste, L

AU - Naesens, L

AU - Maes, P

AU - Grifoni, A

AU - Weiskopf, D

AU - Sette, A

AU - Depuydt, P

AU - Van Braeckel, E

AU - Haerynck, F

AU - Lambrecht, Bart

PY - 2020

Y1 - 2020

U2 - 10.3389/fimmu.2020.596761

DO - 10.3389/fimmu.2020.596761

M3 - Article

C2 - 33329586

SN - 1664-3224

VL - 11

JO - Frontiers in Immunology

JF - Frontiers in Immunology

M1 - 596761

ER -